262 related articles for article (PubMed ID: 31026023)
1. Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
Grewal JK; Tessier-Cloutier B; Jones M; Gakkhar S; Ma Y; Moore R; Mungall AJ; Zhao Y; Taylor MD; Gelmon K; Lim H; Renouf D; Laskin J; Marra M; Yip S; Jones SJM
JAMA Netw Open; 2019 Apr; 2(4):e192597. PubMed ID: 31026023
[TBL] [Abstract][Full Text] [Related]
2. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
[TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis of pleural mesothelioma using Logic Learning Machine.
Parodi S; Filiberti R; Marroni P; Libener R; Ivaldi GP; Mussap M; Ferrari E; Manneschi C; Montani E; Muselli M
BMC Bioinformatics; 2015; 16 Suppl 9(Suppl 9):S3. PubMed ID: 26051106
[TBL] [Abstract][Full Text] [Related]
4. Integrated Histogenetic Analysis Reveals
Bochtler T; Endris V; Reiling A; Leichsenring J; Schweiger MR; Klein S; Stögbauer F; Goeppert B; Schirmacher P; Krämer A; Stenzinger A
J Natl Compr Canc Netw; 2018 Jun; 16(6):677-682. PubMed ID: 29891518
[TBL] [Abstract][Full Text] [Related]
5. New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center.
Galateau Salle F; Le Stang N; Nicholson AG; Pissaloux D; Churg A; Klebe S; Roggli VL; Tazelaar HD; Vignaud JM; Attanoos R; Beasley MB; Begueret H; Capron F; Chirieac L; Copin MC; Dacic S; Danel C; Foulet-Roge A; Gibbs A; Giusiano-Courcambeck S; Hiroshima K; Hofman V; Husain AN; Kerr K; Marchevsky A; Nabeshima K; Picquenot JM; Rouquette I; Sagan C; Sauter JL; Thivolet F; Travis WD; Tsao MS; Weynand B; Damiola F; Scherpereel A; Pairon JC; Lantuejoul S; Rusch V; Girard N
J Thorac Oncol; 2018 Aug; 13(8):1189-1203. PubMed ID: 29723687
[TBL] [Abstract][Full Text] [Related]
6. BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas.
Hwang HC; Pyott S; Rodriguez S; Cindric A; Carr A; Michelsen C; Thompson K; Tse CH; Gown AM; Churg A
Am J Surg Pathol; 2016 May; 40(5):714-8. PubMed ID: 26900815
[TBL] [Abstract][Full Text] [Related]
7. Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts.
Choi Y; Qu J; Wu S; Hao Y; Zhang J; Ning J; Yang X; Lofaro L; Pankratz DG; Babiarz J; Walsh PS; Billatos E; Lenburg ME; Kennedy GC; McAuliffe J; Huang J
BMC Med Genomics; 2020 Oct; 13(Suppl 10):151. PubMed ID: 33087128
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis.
Wu D; Hiroshima K; Matsumoto S; Nabeshima K; Yusa T; Ozaki D; Fujino M; Yamakawa H; Nakatani Y; Tada Y; Shimada H; Tagawa M
Am J Clin Pathol; 2013 Jan; 139(1):39-46. PubMed ID: 23270897
[TBL] [Abstract][Full Text] [Related]
9. The impact of whole genome and transcriptome analysis (WGTA) on predictive biomarker discovery and diagnostic accuracy of advanced malignancies.
Tessier-Cloutier B; Grewal JK; Jones MR; Pleasance E; Shen Y; Cai E; Dunham C; Hoang L; Horst B; Huntsman DG; Ionescu D; Karnezis AN; Lee AF; Lee CH; Lee TH; Twa DD; Mungall AJ; Mungall K; Naso JR; Ng T; Schaeffer DF; Sheffield BS; Skinnider B; Smith T; Williamson L; Zhong E; Regier DA; Laskin J; Marra MA; Gilks CB; Jones SJ; Yip S
J Pathol Clin Res; 2022 Jul; 8(4):395-407. PubMed ID: 35257510
[TBL] [Abstract][Full Text] [Related]
10. Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data.
Bagante F; Spolverato G; Ruzzenente A; Luchini C; Tsilimigras DI; Campagnaro T; Conci S; Corbo V; Scarpa A; Guglielmi A; Pawlik TM
Eur J Cancer; 2021 May; 148():348-358. PubMed ID: 33774439
[TBL] [Abstract][Full Text] [Related]
11. Pathology reporting of malignant pleural mesothelioma first diagnosis: A population-based approach.
Ascoli V; Minelli G; Cozzi I; Romeo E; Carnovale Scalzo C; Ancona L; Forastiere F
Pathol Res Pract; 2016 Oct; 212(10):886-892. PubMed ID: 27485167
[TBL] [Abstract][Full Text] [Related]
12. TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen.
Marquard AM; Birkbak NJ; Thomas CE; Favero F; Krzystanek M; Lefebvre C; Ferté C; Jamal-Hanjani M; Wilson GA; Shafi S; Swanton C; André F; Szallasi Z; Eklund AC
BMC Med Genomics; 2015 Oct; 8():58. PubMed ID: 26429708
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of BRCA1-associated protein-1, glucose transporter-1 and desmin expression in the discrimination between reactive mesothelial proliferation and malignant mesothelioma in tissues and effusions.
Önder S; Özogul E; Koksal D; Sarinc Ulasli S; Firat P; Emri S
Cytopathology; 2019 Nov; 30(6):592-600. PubMed ID: 31165505
[TBL] [Abstract][Full Text] [Related]
14. Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis.
Bruno R; Alì G; Giannini R; Proietti A; Lucchi M; Chella A; Melfi F; Mussi A; Fontanini G
Oncotarget; 2017 Jan; 8(2):2758-2770. PubMed ID: 27835874
[TBL] [Abstract][Full Text] [Related]
15. CancerNet: a unified deep learning network for pan-cancer diagnostics.
Gore S; Azad RK
BMC Bioinformatics; 2022 Jun; 23(1):229. PubMed ID: 35698059
[TBL] [Abstract][Full Text] [Related]
16. Melan A (A103) is not a marker of mesothelioma.
Ordóñez NG; Shen SS; Zenali M; Deavers MT
Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):181-4. PubMed ID: 22820661
[TBL] [Abstract][Full Text] [Related]
17. MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data.
Pasello G; Urso L; Mencoboni M; Grosso F; Ceresoli GL; Lunardi F; Vuljan SE; Bertorelle R; Sacchetto V; Ciminale V; Rea F; Favaretto A; Conte P; Calabrese F
Oncotarget; 2015 Dec; 6(39):42053-66. PubMed ID: 26544728
[TBL] [Abstract][Full Text] [Related]
18. Convolutional neural network models for cancer type prediction based on gene expression.
Mostavi M; Chiu YC; Huang Y; Chen Y
BMC Med Genomics; 2020 Apr; 13(Suppl 5):44. PubMed ID: 32241303
[TBL] [Abstract][Full Text] [Related]
19. Mesotheliomas show higher hyaluronan positivity around tumor cells than metastatic pulmonary adenocarcinomas.
Törrönen K; Soini Y; Pääkkö P; Parkkinen J; Sironen R; Rilla K
Histol Histopathol; 2016 Oct; 31(10):1113-22. PubMed ID: 26912058
[TBL] [Abstract][Full Text] [Related]
20. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
Capkova L; Koubkova L; Kodet R
Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
